drugs

Bristol-Myers, Wyeth Post Higher 2Q Profits >BMY WYE - Wall Street Journal
Washington PostBristol-Myers, Wyeth Post Higher 2Q Profits >BMY WYEWall Street JournalBoth companies faced headwinds from unfavorable currency-exchange rates, the weak economy and competition from cheaper generic drugs. ...Bristol-Myers Buys Medarex Drugmaker for $2.4 BillionBloombergBristol-Myers, Wyeth turn in strong 2Q resultsThe Associated PressBristol-Myers Squibb Bets Big on a MouseBusinessWeekCNNMoney.com�-Bloomberg�-The Associated Pressall 444 news articles��